SMART Africa (Strengthening Mental Health Research and Training) (SMART)

November 20, 2024 updated by: Fred Ssewamala, Washington University School of Medicine

SMART Africa: Addressing African Youth Mental Health by Scaling Family and Community-Level EBPs

The objective of this research study is to examine the implementation of and outcomes associated with an evidence-based practice (EBP), specifically Multiple Family Group (MFG) targeting youth disruptive behavior challenges and success, through a scale up intervention study in Uganda, and two pilot studies that will be conducted in Kenya and Ghana.

Study Overview

Detailed Description

A longitudinal experimental mixed methods effectiveness-implementation hybrid research design will be employed. The study will be conducted across thirty primary schools representing both semi-urban and rural communities. We expect to involve 3,000 youth (in primary schools grades 2 through 7; 8 to 13 years) and their adult caregivers (3,000) in Uganda, 180 youth and their caregivers (180) in Ghana, and 180 youth and their caregivers (180) in Kenya.

Schools will be randomly assigned to 3 study conditions: 1) MFG-delivered by trained family peers; 2) MFG-delivered by community health workers (school health education program coordinators in Ghana); or, 3) Comparison: mental health and school support materials (e.g., books, uniforms). Data will be collected at baseline, 8 and 16 weeks, and 6 months follow-up (10 months from baseline).

More specifically the objectives of this study are:

Primary objectives

  1. To examine short- and long-term outcomes associated with the MFG. Hypothesis: Children in the treatment groups (MFG) will improve significantly more compared to those in the comparison (usual care) group.
  2. To examine how systematic variations in the delivery of an evidence-based MFG program impacts outcomes for children with behavioral difficulties and their caregivers in each country context.

    Hypothesis: Children who participate in MFG with their families will display significantly reduced conduct difficulties and increased functioning over time compared to those involved in comparison condition. We expect that parent peers - compared to community health workers - will evidence significantly more success engaging families to attend MFG sessions, thus, children in the MFG-parent peer delivered condition will evidence the great improvement relative to the other two study conditions.

    Secondary objectives

  3. To compare the uptake and implementation of MFGs by trained existing family peers and community outreach health workers.

    Hypothesis: Given the level of training that community outreach health workers have received prior to the study as part of their regular professional training, they will evidence higher fidelity initially, yet with training and ongoing supervision, we expect these differences to decrease over time.

  4. To examine multi-level (state/government, NGOs, families, schools, communities) influences on the uptake, implementation, effectiveness and sustainability of EBPs that address serious child disruptive behavioral challenges.

Study Type

Interventional

Enrollment (Actual)

3117

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Accra, Ghana
        • University of Ghana
      • Nairobi, Kenya
        • University of Nairobi
      • Masaka, Uganda
        • Reach the Youth Uganda
    • Missouri
      • St. Louis, Missouri, United States, 63130
        • Washington University in St. Louis

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 99 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

- Inclusion criteria for caregiver/child dyads:

  • Adult caregiver of a child in primary school, grades two through 7, ages 8 to 13 years
  • Adult caregiver willing to consent and available for research and intervention activities
  • Child between the ages 8 to 13 or in primary school (grades two through seven) who is screened for ODD or CD as measured by the Disruptive Behavior Disorder Rating Scale, Impairment Scale, and Iowa Conners Scale.
  • Child willing to assent.

    • Inclusion criteria for parent peers:
  • Caregivers of children who agree to be trained to provide support to families.

    • Inclusion criteria for community health workers
  • Lay paraprofessionals who work within primary care settings.

    • Inclusion criteria for school directors
  • Directors who oversee schools where the proposed intervention will have been tested.

Exclusion Criteria:

- Exclusion criteria for caregiver/child dyads:

  • Lack of understanding of study and study procedures as determined by the research team
  • Child or caregiver refusal to participate

    • Exclusion criteria for parent peers:
  • Refusal to participate

    • Exclusion criteria for community health workers
  • Refusal to participate

    • Exclusion criteria for school directors
  • Refusal to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: MFG-delivered by trained family peers

MFG delivered by trained parent peers drawn from local school planning councils:

10 schools; 60 parent peers (6 per school x 10); 1,000 children and adult caregivers; children screened to evidence serious emerging and clinically significant DBDs

The MFG is a series of weekly meetings guided by a protocol.Over the course of 16 weeks, groups are held weekly and are facilitated by trained and supervised group leaders (in this case either parent peers or community health outreach workers). Groups can consist of up to 20 families involving adult caregivers and all children over six years of age in the family. The protocols have been designed to provide opportunities during each session to directly apply content to the realities of family life, emergent cultural and values perspectives, as well as tailor messages to age of child. Redundancy for missed appointments and opportunities for reinforcement is built in. We aim for families to attend at least 8 meetings or more (out of 16 sessions in total), as findings suggests this dose is needed to reduce child conduct problems and the majority of families reach this goal.
Other Names:
  • 4Rs and 2Ss
  • Amaka Amasanyufu (Happy Families in Luganda-Uganda)
  • Dang-Malgu (Family Togetherness in Dagbani-Ghana)
Experimental: MFG-delivered by CHWs

MFG delivered by community health workers (CHW) drawn from local primary care clinics:

10 schools; 60 community health workers (6 assigned to children per school x 10); 1,000 children and adult caregivers; children screened to evidence serious emerging and clinically significant DBDs

The MFG is a series of weekly meetings guided by a protocol.Over the course of 16 weeks, groups are held weekly and are facilitated by trained and supervised group leaders (in this case either parent peers or community health outreach workers). Groups can consist of up to 20 families involving adult caregivers and all children over six years of age in the family. The protocols have been designed to provide opportunities during each session to directly apply content to the realities of family life, emergent cultural and values perspectives, as well as tailor messages to age of child. Redundancy for missed appointments and opportunities for reinforcement is built in. We aim for families to attend at least 8 meetings or more (out of 16 sessions in total), as findings suggests this dose is needed to reduce child conduct problems and the majority of families reach this goal.
Other Names:
  • 4Rs and 2Ss
  • Amaka Amasanyufu (Happy Families in Luganda-Uganda)
  • Dang-Malgu (Family Togetherness in Dagbani-Ghana)
No Intervention: Bolstered care

Comparison (Bolstered care): Mental health wellness materials and educational supports (e.g. books, uniforms)

10 schools; 1,000 children and adult caregivers; children screened to evidence serious emerging and clinically significant DBDs

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Child disruptive behavior
Time Frame: baseline, 8 weeks, 16 weeks, 6 months
Change in disruptive behavior will be measured by Iowa Connors
baseline, 8 weeks, 16 weeks, 6 months
Child impairment
Time Frame: baseline, 8 weeks, 16 weeks, 6 months
Change in disruptive behavior will be measured Impairment scale
baseline, 8 weeks, 16 weeks, 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Implementation and Feasibility
Time Frame: 8 weeks, 16 weeks, 6 months
implementation and feasibility checklist measures
8 weeks, 16 weeks, 6 months
Fidelity
Time Frame: end of session at week 1, week 2, week 3, week 4, week 6, week 7, week 8, week 9, week 10, week 11, week 12, week 13, week 14, week 15, week 16
MFG Intervention Fidelity Assessment measures
end of session at week 1, week 2, week 3, week 4, week 6, week 7, week 8, week 9, week 10, week 11, week 12, week 13, week 14, week 15, week 16
Sustainability
Time Frame: 8 weeks, 16 weeks, 6 months
Program Sustainability Assessment Tool
8 weeks, 16 weeks, 6 months
Implementation process
Time Frame: 8 weeks, 16 weeks, 6 months
Metropolitan Area Child Study process measure
8 weeks, 16 weeks, 6 months
Parenting
Time Frame: baseline, 8 weeks, 16 weeks, 6 months
Change in parenting will be measured by Alabama Parenting questionnaire
baseline, 8 weeks, 16 weeks, 6 months
Social support
Time Frame: baseline, 8 weeks, 16 weeks, 6 months
Improvement in social support will be measured by Multidimensional scale of perceived social support -modified
baseline, 8 weeks, 16 weeks, 6 months
Caregiver depression
Time Frame: baseline, 8 weeks, 16 weeks, 6 months
Change in caregiver depression will be measured by Center for Epidemiologic Studies Short Depression Scale
baseline, 8 weeks, 16 weeks, 6 months
Caregiver mental health
Time Frame: baseline, 8 weeks, 16 weeks, 6 months
Change in caregiver mental health will be measured by Brief Symptom Checklist
baseline, 8 weeks, 16 weeks, 6 months
Caregiver stress
Time Frame: baseline, 8 weeks, 16 weeks, 6 months
Change in caregiver stress will be measured by parent stress index short form
baseline, 8 weeks, 16 weeks, 6 months
Child mental health
Time Frame: baseline, 8 weeks, 16 weeks, 6 months
Change in Child mental health will be measured by Strengths and Difficulties questionnaire
baseline, 8 weeks, 16 weeks, 6 months
Child self-concept
Time Frame: baseline, 8 weeks, 16 weeks, 6 months
Change in child self-concept will be measured by tennessee self-concept
baseline, 8 weeks, 16 weeks, 6 months
Child depression
Time Frame: baseline, 8 weeks, 16 weeks, 6 months
Change in child depression will be measured by child depression scale
baseline, 8 weeks, 16 weeks, 6 months
Family relations
Time Frame: baseline, 8 weeks, 16 weeks, 6 months
Change in family relations will be measured by Family Relations and Cohesion scale
baseline, 8 weeks, 16 weeks, 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Fred Ssewamala, PhD, Washington University School of Medicine
  • Principal Investigator: Mary McKay, PhD, Washington University School of Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 6, 2017

Primary Completion (Actual)

May 31, 2021

Study Completion (Actual)

May 31, 2021

Study Registration Dates

First Submitted

February 23, 2017

First Submitted That Met QC Criteria

March 15, 2017

First Posted (Actual)

March 16, 2017

Study Record Updates

Last Update Posted (Actual)

November 25, 2024

Last Update Submitted That Met QC Criteria

November 20, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • U19MH110001-011
  • U19MH110001 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There will be no individual participant data that will be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Comparison Group

Clinical Trials on MFG

Subscribe